Tag: Corporate

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

AmpliTech Group Strengthens ORAN 5G Growth Strategy with Addition of Two Senior Business Development Leaders

CHARLOTTE, N.C., June 16, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) is pleased to announce that it has...

NASDAQ: EUTSXV: EUwww.encoreuranium.comDALLAS, June 16, 2026 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, reports positive...

Broadridge-backed LTX integrates real-time, actionable agentic AI directly into daily fixed income trading workflowsNEW YORK, June 16, 2026 /PRNewswire/ -- LTX, an AI-powered corporate bond...

TSX: TVECALGARY, AB, June 16, 2026 /CNW/ - Tamarack Valley Energy Ltd. has successfully closed the previously announced sale of its Charlie Lake assets for...

Next-generation semantic intelligence platform accelerates enterprise AI modernization by 3X while ensuring strict compliance for regulated industries.LONDON, June 16, 2026 /PRNewswire/ -- Onix today...

Claret Capital Partners is providing growth funding of €43m as part of Inventiva’s €130m debt financing, to support its lead asset through Phase 3.

MUMBAI, India, June 16, 2026 /PRNewswire/ -- InCred Capital, the institutional, wealth and asset management arm of InCred Group, today announced the launch of...

AS LHV Group’s May financial results reflected positive performance, with the results of all subsidiaries in line with the financial plan. LHV Group earned a consolidated net profit of EUR 9.1 million in May, with return on equity attributable to shareholders of 14.1%. Among the subsidiaries, AS LHV Pank earned EUR 9.8 million, LHV Bank Ltd EUR 0.3 million, AS LHV Varahaldus EUR 0.2 million and AS LHV Kindlustus EUR 0.4 million in net profit.

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

OSCEOLA, Ark., June 15, 2026 /PRNewswire/ -- Hybar LLC ("Hybar") announced today the pricing of the previously announced offering (the "Offering") of $400,000,000 aggregate...

Feature Film Marks Acting Debut for Combat Sports Star; Pre-Production UnderwayTOKYO, June 15, 2026 /PRNewswire/ -- The LeMarco Group GK today announced that celebrated...